Remdesivir (código de desarrollo GS-5734) es un m...

wikipedia - 13 Mar 2021
Remdesivir (código de desarrollo GS-5734) es un medicamento antiviral, un nuevo profármaco que pertenece al grupo de los análogos de nucleótidos. La vía de administración es mediante inyección intravenosa y oral en infusión. Actualmente, se encuentra en estudios experimentales con pacientes con COVID-19, no obstante su uso incrementa el riesgo de daño a los riñones.

Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a ...

Nature.com - 23 Apr 2024
Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a ... ...

Remdesivir tied to 25% lower risk of in-hospital death in adults with COVID and no added oxygen

University of Minnesota Twin Cities - 17 Apr 2024
Remdesivir tied to 25% lower risk of in-hospital death in adults with COVID and no added oxygen ...

COVID-19 Treatments: What We Know So Far > News

Yale Medicine - 26 May 2023
COVID-19 Treatments: What We Know So Far > News ...

Information about outpatient COVID-19 therapeutics for health care providers | Department of Public Health ...

Colorado Department of Public Health and Environment - 18 Jan 2024
Information about outpatient COVID-19 therapeutics for health care providers | Department of Public Health ... ...

Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID ...

Nature.com - 05 Mar 2024
Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID ... ...

Coronavirus (COVID-19) | Drugs

FDA.gov - 29 Dec 2023
Coronavirus (COVID-19) | Drugs ...

Two cases show COVID virus mutating around standard treatment remdesivir

Medical Xpress - 23 Jan 2024
Two cases show COVID virus mutating around standard treatment remdesivir ...

WHO updates guidelines on treatments for COVID-19

World Health Organization (WHO) - 10 Nov 2023
WHO updates guidelines on treatments for COVID-19 ...

COVID-19 Mortality and Remdesivir – A Retrospective Cohort in Intensive Care Setting

Cureus - 23 Dec 2023
COVID-19 Mortality and Remdesivir – A Retrospective Cohort in Intensive Care Setting ...

Safety of Remdesivir in Patients With Reduced Renal Function

DocWire News - 05 Feb 2024
Safety of Remdesivir in Patients With Reduced Renal Function ...

Pulmonary delivery of remdesivir and dexamethasone encapsulated nanostructured lipid carriers for enhanced ...

ScienceDirect.com - 04 Nov 2023
Pulmonary delivery of remdesivir and dexamethasone encapsulated nanostructured lipid carriers for enhanced ... ...

Remdesivir spurs faster COVID recovery; does not affect mortality, large new study finds

McKnight's Long-Term Care News - 21 Apr 2024
Remdesivir spurs faster COVID recovery; does not affect mortality, large new study finds ...

Remdesivir tied to lower COVID death rates in hospital patients receiving oxygen

University of Minnesota Twin Cities - 22 Sep 2023
Remdesivir tied to lower COVID death rates in hospital patients receiving oxygen ...

Final report confirms remdesivir benefits for COVID-19

National Institutes of Health (NIH) (.gov) - 20 Oct 2020
Final report confirms remdesivir benefits for COVID-19 ...

FDA Approves First Treatment for COVID-19

FDA.gov - 22 Oct 2020
FDA Approves First Treatment for COVID-19 ...

Concentrations of remdesivir and GS-441524 in human milk from lactating individuals diagnosed with COVID-19 ...

Nature.com - 12 Feb 2024
Concentrations of remdesivir and GS-441524 in human milk from lactating individuals diagnosed with COVID-19 ... ...

NIH clinical trial of remdesivir to treat COVID-19 begins

National Institutes of Health (NIH) (.gov) - 25 Feb 2020
NIH clinical trial of remdesivir to treat COVID-19 begins ...

Remdesivir tied to lower death rates in COVID hospital patients with weakened immune systems

University of Minnesota Twin Cities - 10 Aug 2023
Remdesivir tied to lower death rates in COVID hospital patients with weakened immune systems ...

Remdesivir increases mtDNA copy number causing mild alterations to oxidative phosphorylation | Scientific Reports

Nature.com - 15 Sep 2023
Remdesivir increases mtDNA copy number causing mild alterations to oxidative phosphorylation | Scientific Reports ...

Remdesivir